As the demand for cardiac care in the US continues to rise, and as more patients are screened and treated for cardiovascular disease, cardiac catheterization and percutaneous coronary intervention ...

CMS recently announced the final Outpatient Prospective Payment System rule for fiscal year 2019, invasive cardiac diagnostic procedures join the ranks of the newest procedures to be conducted in the ...

According to results published in Catheterization and Cardiovascular Interventions, announcing endovascular equipment, implant and medication costs in the catheterization lab can significantly affect ...

New integration of Philips Advanced Visualization Workspace* with the Azurion image-guided therapy platform automatically synchronizes CT images with C-arm movement, supporting workflow efficiency and ...

NATICK, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, a leading developer of precision vascular robotics, announced today that the clinical trial of its CorPath® PRECISE (Percutaneous ...

A first-of-its kind study using robotic technology to remotely control coronary guidewires and stents reported on the feasibility of performing percutaneous coronary intervention (PCI) on patients ...

Performing PCI with the assistance of a robotic system may be one way that cardiac cath lab personnel can minimize risks of contracting SARS-CoV-2 and other infectious diseases, a proof-of-concept ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. PCI improved angina symptoms at 12 weeks vs. a sham ...

More than 700,000 PCI procedures each year in the U.S. require effective antithrombin and antiplatelet therapy. KENGREAL has the potential to address the unmet needs of these patients and is ...

WALTHAM, Mass., Corindus Vascular Robotics, a leading developer of precision vascular robotics, announced today that the U.S. Food and Drug Administration has given 510(k) clearance for its ...

San Francisco, USA and Amsterdam, The Netherlands – At the annual Transcatheter Cardiovascular Therapeutics (TCT 2025) meeting, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health ...